Zila, Inc. is an international provider of pharmaceutical, biotechnology, and nutraceutical products for dental/medical professionals...

90.2K

Verified Solution

Question

Accounting

Zila, Inc. is an international provider of pharmaceutical, biotechnology, and nutraceutical products for dental/medical professionals and consumers. One of Zilas recent major projects is a method to detect oral cancer for which Zila is awaiting FDA approval on. Captions of their statement of operations, balance sheet and cash flow are presented below.

Balance Sheet Data

2001

2000

Cash and cash equivalents

$1,651,266

$5,558,487

Accounts receivable, net of allowance of $312,061 (2001) and $345,857 (2000)

10,412,372

9,893,587

Inventories

17,751,148

13,204,137

Total current assets

32,069,550

31,380,071

Property & equipment (net)

9,843,103

9,442,278

Total assets

76,557,129

77,711,459

Total current liabilities

15,683,253

11,050,668

Short-term borrowings

6,160,947

51,770

Total debt

19,836,524

15,599,621

Selected Income Statement Data

2001

2000

1999

Net sales

$73,724,923

$77,580,908

$71,294,751

Cost of products sold

41,425,083

40,004,391

34,355,344

Gross Profit

32,299,840

37,576,517

36,939,407

Selling, general, and admin. expense

31,864,041

32,449,161

31,853,421

Operating profit (loss)

(6,125,804)

20,656

(2,463,810)

Interest expense

596,870

2,112,671

392,805

Net income (loss)

(6,313,823)

2,932,027

(1,966,982)

Selected Cash Flow Data

2001

2000

1999

Net cash provided from operating activities

($8,683,507)

$2,329,653

($791,581)

You assemble the following ratios:

2000 2001 Industry
Current ratio 2.84% 2.04% 1.5%
Quick ratio 1.64% 0.91% 0.9%
Average collection period 46.55 days 51.55 days 50 days
Days inventory held 120.47 days 156.41 days 67 days
Fixed asset turnover 8.22X 7.49X 37.2X
Total asset turnover 1.00X 0.96X 2.6X
Debt to total assets 20% 26% 65.3%
Times interest earned 0.01X -10.26X 3.4X
Gross profit margin 48.44% 43.81% 30.6%
Operating profit margin 0.03% -8.31% 5.2%

Industry ratios from Robert Morris Associates, Annual Statement Studies, 2001; SIC #5047

  1. Comment on the firms liquidity position in terms of the current and quick ratio. Which of the two ratios is deteriorating more? What does this imply?
  2. Comment on the average collection period.
  3. The management of which current asset(s) would be of most concern to the financial analyst? Explain.
  4. Zilas total debt has risen since 2000. Is their capital structure more or less risky than the industry? Explain.
  5. What concerns would creditors have about their stake in Zila?
  6. Discuss the companys profitability.
  7. Given the overall circumstances surrounding Zila, list two reasons for and two reasons against making an investment in Zila.

Reasons for:

Reasons against:

Answer & Explanation Solved by verified expert
Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:
  • Unlimited Question Access with detailed Answers
  • Zin AI - 3 Million Words
  • 10 Dall-E 3 Images
  • 20 Plot Generations
  • Conversation with Dialogue Memory
  • No Ads, Ever!
  • Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
Become a Member

Other questions asked by students